News
HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...
A team of leading infectious disease scientists from academia and industry have been awarded £17.9 million to identify new ...
A team of leading infectious disease scientists from academia and industry have been awarded £17.9 million to identify new ...
If South Africa had an official pastime beyond braaiing and sports, it might just be making plans, to make plans. This can be true of sustainability plans... they can find themselves caught between ...
BactiVac showcases expertise at the World Vaccine Congress 2025, championing global equity and innovation in bacterial vaccine development.
On the WPP Media S Asia Executive Committee are - Priti Murthy, Ajay Gupte, Amin Lakhani, Navin Khemka, Vishandas Hardasani, ...
Even with the HIV prevention waters now dominated by Gilead Science’s Yeztugo (lenacapavir), Merck & Co. is not afraid to swim deeper in. | Even with the HIV prevention waters now dominated by Gilead ...
The chatbot is giving antisemitic responses and bizarre first-person replies, raising concerns about bias and safety ahead of Grok 4 launch.
The sharpest fall was seen at the brand level, with only 14 brands advertising during the 2025 final, a drastic drop from 70 ...
2d
Zacks Investment Research on MSNMerck Starts Phase III Studies on Once-Monthly Pill for HIV PreventionMerck MRK recently launched two late-stage clinical studies to evaluate MK-8527, its investigational once-monthly oral pill for HIV pre-exposure prophylaxis (PrEP). The EXPrESSIVE-11 study, which ...
Following WPP Media South Asia’s recent announcement of its revamped leadership structure, and its formal transition to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results